Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: Updating a 1983 review

Rheumatology

Volumn 41, Issue 12, 2002, Pages 1346-1356

  Pincus, T ^a   Ferraccioli, G ^b   Sokka, T ^a,c   Larsen, A ^d   Rau, R ^e   Kushner, I ^f   Wolfe, F ^g  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Section of Oncology and Molecular Pathology   (Italy)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d Rheumatology Department   (Norway)

^e Evangelisches Fach krankenhaus Ratingen   (Germany)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CORTISONE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; GOLD SALT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE;

CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; JOINT RADIOGRAPHY; LONG TERM CARE; MEDICAL DOCUMENTATION; PATIENT CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036905477     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/41.12.1346     Document Type: Review

References (124)

1. Pincus T, Callahan LF. The 'side effects' of rheumatoid arthritis: Joint destruction, disability and early mortality. Br J Rheumatol 1993;32(Suppl. 1):28-37.
2. Emery P, Salmon M. Early rheumatoid. Arthritis: time to aim for remission? Ann Rheum Dis 1995;54:944-7.
3. Weinblatt ME. Rheumatoid arthritis: Treat now, not later! [Editorial]. Ann Intern Med 1996;124:773-4.
4. Paulus HE, Egger MJ, Ward JR, Williams HJ, Cooperative Systematic Studies of Rheumatic Diseases Group. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990;33:477-84.
5. Pincus T, O'Dell JR, Kremer JM. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: A preventive strategy. Ann Intern Med 1999;131:768-74.
6. Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis 1984; 43:8-17.
7. Hassell AB, Davis MJ, Fowler PD et al. The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. Q J Med 1993;86:601-7.
8. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
9. Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: Evidence that pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996; 35:1263-8.
10. Callahan LF, Pincus T, Huston JW III, Brooks RH, Nance EP Jr, Kaye JJ. Measures of activity and damage in rheumatoid arthritis: Depiction of changes and prediction of mortality over five years. Arthritis Care Res 1997; 10:381-94.
11. Leirisalo-Repo M, Paimela L, Peltomaa R et al. Functional and radiological outcome in patients with early RA-A longitudinal observational study [abstract]. Arthritis Rheum 1999;42:S130.
12. Graudal N, Tarp U, Jurik AG et al. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: Longterm course and association to radiographic progression. J Rheumatol 2000;27:47-57.
13. Wollheim FA. Disease modifying drugs in rheumatoid arthritis. Br Med J 1997;314:766-7.
14. Kirwan JR. Conceptual issues in scoring radiographic progression in rheumatoid arthritis. J Rheumatol 1999; 26:720-5.
15. Kirwan JR, Currey HLF. Rheumatoid arthritis: disease-modifying antirheumatic drugs. Clin Rheum Dis 1983; 9:581-99.
16. Kelley WN, Harris ED Jr, Ruddy S, Sledge CB. Textbook of rheumatology. Philadelphia: W.B. Saunders, 1985.
17. Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum 1996; 39:616-22.
18. Iannuzzi L, Dawson N, Zein N, Kushner I. Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 1983;309:1023-8.
19. Kremer JL, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986;29:822-31.
20. Weinblatt ME, Coblyn JS, Fox DA et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818-22.
21. Weinblatt ME, Kaplan H, Germain BF et al. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 1994; 37:1492-8.
22. Kremer JM. Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: Followup after a mean of 13.3 years. Arthritis Rheum 1997;40:984-5.
23. Miescher PA, Favre H, Mihatsch MJ, Chatelanat F, Huang YP, Zubler R. The place of cyclosporine A in the treatment of connective tissue diseases. Transplantation Proc 1988;20:224-37.
24. Dijkmans BAC, van Rijthoven AWAM, Goei The HS, Boers M, Cats A. Cyclosporine in rheumatoid arthritis. Semin Arthritis Rheum 1992;22:30-6.
25. Smolen JS, Kalden JR, Scott DL et al. and the European Leflunomide Study Group. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial. Lancet 1999;353:259-66.
26. Strand V, Cohen S, Schiff M et al. on behalf of the Leflunomide Rheumatoid Arthritis Investigators Group. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999;159:2542-50.
27. Moreland LW, Baumgartner SW, Schiff MH et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
28. Weinblatt ME, Kremer JM, Bankhurst AD et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340:253-9.
29. Maini RN, Breedveld FC, Kalden JR et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
30. Bresnihan B, Alvaro-Gracia JM, Cobby M et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998; 41:2196-204.
31. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971; 14:706-20.
32. Sharp JT, Wolfe F, Mitchell DM, Bloch DA. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum 1991;34:660-8.
33. Larsen A. A radiological method for grading the severity of rheumatoid arthritis. Academic dissertation, University of Helsinki, 1974.
34. Larsen A, Thoen J. Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year. Scand J Rheumatol 1987;16:395-401.
35. Pincus T, Larsen A, Brooks RH, Kaye J, Nance EP, Callahan LF. Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker stage, Kaye modified Sharp score, and Larsen score. J Rheumatol 1997;24:2106-12.
36. Molenaar ET, Edmonds J, Boers M, van der Heijde DM, Lassere M. A practical exercise in reading RA radiographs by the Larsen and Sharp methods. J Rheumatol 1999; 26:746-8.
37. Kaye JJ, Nance EP, Callahan LF et al. Observer variation in quantitative assessment of rheumatoid arthritis: part II. A simplified scoring system. Invest Radiol 1987;22:41-6.
38. van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (Van der Heijde modification). J Rheumatol 1995;22:1792-6.
39. Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 1998;25:2094-107.
40. Pincus T. Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol 1988;41:1037-41.
41. Pincus T. Limitations of randomized controlled clinical trials to recognize possible advantages of combination therapies in rheumatic diseases. Semin Arthritis Rheum 1993;23(Suppl. 1):2-10.
42. Pincus T, Stein CM. Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: Some explanations and suggestions for future studies. Clin Exp Rheumatol 1997;15(Suppl. 17):S27-38.
43. Felson DT, Anderson JJ, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two metaanalyses. Arthritis Rheum 1990;33:1449-61.
44. Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting anti-rheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
45. Pincus T, Marcum SB, Callahan LF. Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second-line drugs and prednisone. J Rheumatol 1992;19:1885-94.
46. Stein CM, Pincus T. Placebo-controlled studies in rheumatoid arthritis: Ethical issues. Lancet 1999; 353:400-3.
47. Thould AK, Simon G. Assessment of radiological changes in the hands and feet in rheumatoid arthritis: their correlation with prognosis. Ann Rheum Dis 1966; 25:220-8.
48. Brook A, Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis 1977;36:71-3.
49. Salaffi F, Ferraccioli GF. Progress of the anatomical damage in rheumatoid hands. Radiography of the natural course of the disease or of the course during treatment? Scand J Rheumatol 1989; 18: 119-20.
50. Pincus T, Callahan LF, Fuchs HA, Larsen A, Kaye J. Quantitative analysis of hand radiographs in rheumatoid arthritis: Time course of radiographic changes, relation to joint examination measures, and comparison of different scoring methods. J Rheumatol 1995;22:1983-9.
51. Kaarela K, Kautiainen H. Continuous progression of radiological destruction in seropositive rheumatoid arthritis. J Rheumatol 1997;24:1285-7.
52. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82.
53. Graudal NA, Jurik AG, de Carvalho A, Graudal HK. Radiographic progression in rheumatoid arthritis: A long-term prospective study of 109 patients. Arthritis Rheum 1998;41:1470-80.
54. Plant MJ, Jones PW, Saklatvala J, Ollier WER, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis: Results of an 8 year prospective study. J Rheumatol 1998;25:417-26.
55. Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR. Gold salts in the treatment of rheumatoid arthritis: a double-blind study. Ann Intern Med 1974; 80:21-6.
56. Research Sub-Committee of the Empire Rheumatism Council. Gold therapy in rheumatoid arthritis: final report of a multicentre controlled trial. Ann Rheum Dis 1961;20:315-34.
57. van Riel PL, Larsen A, van de Putte LB, Gribnau FW. Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis. Clin Rheumatol 1986; 5:359-64.
58. Rau R, Schattenkirchner M, Muller-Fassbender H, Kaik B, Zeidler H, Missler B. A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis. Clin Rheumatol 1990;9:461-74.
59. Rau R, Herborn G, Karger T, Menninger H, Elhardt D, Schmitt J. A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: An interim report on 102 patients after 12 months. Semin Arthritis Rheum 1991;21:13-20.
60. Borg G, Allander E, Lund B, Berg E, Brodin U, Pettersson H, Trang L. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind, placebo controlled study. J Rheumatol 1988;15:1747-54.
61. Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Bordin U, Trang L. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995;22:2208-13.
62. Luukkainen R, Kajander A, Isomaki H. Effect of gold on progression of erosions in rheumatoid arthritis: better results with early treatment. Scand J Rheumatol 1977; 6:189-92.
63. van der Heijde DMFM, van Riel PLCM, Nuver-Zwart IH, Gribnau FWJ, van de Putte LBA. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;i:1036-8.
64. van der Heijde DMFM, van Riel PLCM, Nuver-Zwart IH, van de Putte LBA. Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up [letter]. Lancet 1990;335:539.
65. Pullar T, Hunter JA, Capell HA. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987;46:398-402.
66. Carroll GJ, Will RK, Breidahl PD, Tinsley LM. Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis. Rheumatol Int 1989;8:251-5.
67. Jeurissen MEC, Boerbooms AMT, van de Putte LBA, Doesburg WH, Lemmens AM. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis: A randomized, double-blind study. Ann Intern Med 199 1; 114:999-1004.
68. Weinblatt ME, Polisson R, Blotner SD. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum 1993;36:613-9.
69. Drosos AA, Tsifetaki N, Tsiakou EK et al. Influence of methotrexate on radiographic progression in rheumatoid arthritis: A sixty-month prospective study. Clin Exp Rheumatol 1997;15:263-7.
70. Hanrahan PS, Scrivens GA, Russell AS. Prospective longterm followup of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 1989;28:147-53.
71. Sany J, Kaliski S, Couret M, Cuchacovich M, Daures JP. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol 1990; 17:1636-41.
72. Weinblatt ME, Trentham DE, Fraser PA et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-75.
73. Weinblatt ME, Weissman BN, Holdsworth DE et al. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84-month update. Arthritis Rheum 1992;35:129-37.
74. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis: Update after a mean of fifty-three months. Arthritis Rheum 1988; 31:577-84.
75. Reykdal S, Steinsson K, Sigurjonsson K, Brekkan A. Methotrexate treatment of rheumatoid arthritis: Effects on radiological progression. Scand J Rheumatol 1989; 18:221-6.
76. Rau R, Herborn G, Karger T, Werdier D. Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy: A controlled study. Arthritis Rheum 1991;34:1236-44.
77. Maravic M, Bologna C, Daures JP, Jorgensen C, Combe B, Sany J. Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol 1999; 26:262-7.
78. Rich R, Moreland LW, Alarcon GS. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug. J Rheumatol 1999;26:259-61.
79. Forre O. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine: Results of a 48-week multi-center study comparing low-dose cyclosporine with placebo. Arthritis Rheum 1994;37:1506-12.
80. Pasero G, Priolo F, Marubini E et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996;39:1006-15.
81. Drosos AA, Voulgari PV, Papadopoulos IA, Politi EN, Georgiou PE, Zikou AK. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Clin Exp Rheumatol 1998;16:695-701.
82. van den Borne BEEM, Landewe RBM, The HSG, Breedveld FC, Dijkmans BAC. Low dose cyclosporine in early rheumatoid arthritis: Effective and safe after two years of therapy when compared with chloroquine. Scand J Rheumatol 1996;25:307-16.
83. Zeidler HK, Kvien TK, Hannonen P et al. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: Comparison of low-dose cyclosporin and parenteral gold. Br J Rheumatol 1998; 37:874-82.
84. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of RA: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 2000;43:495-505.
85. Bathon JM, Martin RW, Fleischmann RM et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000-1 343:1586-93.
86. Elliott MJ, Maini RN, Feldman M et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor a. Arthritis Rheum 1993; 36:1681-90.
87. Elliott MJ, Maini RN, Feldmann M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
88. Lipsky PE, van der Heijde DMFM, Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
89. Jiang Y, Genant HK, Watt I et al. A multicenter, doubleblind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000;43:1001-9.
90. Rau R, Herborn G, Sander O, van de Putte LBA et al. Long-term treatment with the fully human anti-TNF-antibody D2E7 slows radiographic disease progression in rheumatoid arthritis. Arthritis Rheum 1999; 42(S400): Abstract 1978.
91. den Broeder AA, Joosten LA, Saxne T, Heinegard D, Fenner H, Miltenburg AMM. Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. Ann Rheum Dis 2002;61:311-8.
92. Weiss MM. Corticosteroids in rheumatoid arthritis. Semin Arthritis Rheum 1989;19:9-21.
93. George E, Kirwan JR. Corticosteroid therapy in rheumatoid arthritis. Bailliere's Clin Rheumatol 1990; 4:621-46.
94. Weusten BLAM, Jacobs JWG, Bijlsma JWJ. Corticosteroid pulse therapy in active rheumatoid arthritis. Semin Arthritis Rheum 1993;23:183-92.
95. Saag KG, Criswell LA, Sems KM, Nettleman MD, Kolluri S. Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness. Arthritis Rheum 1996;39:1818-25.
96. Empire Rheumatism Council. Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Ann Rheum Dis 1955;14:353-67.
97. Joint Committee of the Medical Research Council, Nuffield Foundation. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959;18:173-88.
98. West HF. Rheumatoid arthritis: The relevance of clinical knowledge to research activities. Abstr World Med 1967; 41:401-17.
99. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
100. Rau R, Wassenberg S, Zeidler H. Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis. Z Rheumatol 2000;59:90-6.
101. van Everdingen AA, Jacobs JWG, van Reesema DRS, Bijlsma JWJ. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: a double-blind placebo controlled clinical trial. Ann Intern Med 2002; 136:1-12.
102. Boers M, Verhoeven AC, Markusse HM et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine in early rheumatoid arthritis. Lancet 1997; 350:309-18.
103. Landewe RBM, Boers M, Verhoeven AC et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
104. Mottonen T, Hannonen P, Leirisalo-Repo M et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial. FIN-RACo trial group. Lancet 1999;353:1568-73.
105. Korpela M, Mottonen T, Laasonen L, Kautiainen H, Hannonen P, Leirisalo-Repo M. The impact of initial aggressive drug treatment with DMARDs on the development of joint damage in the long term in patients with rheumatoid arthritis (RA). The 5-year experience from the FIN-RACo study [abstract]. Arthritis Rheum 2001;44(9 Suppl.):S153.
106. Alarcon GS, Lopez-Mendez A, Walter J et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1868-73.
107. van Riel PLCM, van der Heijde DMFM, Nuver-Zwart IH, van de Putte LBA. Radiographic progression in rheumatoid arthritis: Results of 3 comparative trials. J Rheumatol 1995;22:1797-9.
108. Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of cyclophosphamide in rheumatoid arthritis. N Engl J Med 1970; 283:883-9.
109. McCarty DJ, Carrera GF. Intractable rheumatoid arthritis: treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. J Am Med Assoc 1982;248:1718 23.
110. Jalava S, Reunanen K. Healing of erosions in rheumatoid arthritis. Scand J Rheumatol 1982; 11:97-100.
111. Menninger H, Meixner C, Sondgen W. Progression and repair in radiographs of hands and forefeet in early rheumatoid arthritis. J Rheumatol 1995; 22:1048-54.
112. Rau R, Herborn G. Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease-modifying antirheumatic drug therapy. Arthritis Rheum 1996;39:162-8.
113. Sokka T, Hannonen P. Healing of erosions in rheumatoid arthritis. Ann Rheum Dis 2000;59:647-9.
114. Abu-Shakra M, Toker R, Flusser D et al. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs. Arthritis Rheum 1998;41:1190-5.
115. Sokka TM, Kaarela K, Mottonen TT, Hannonen PJ. Conventional monotherapy compared to a 'sawtooth' treatment strategy in the radiographic procession of rheumatoid arthritis over the first eight years. Clin Exp Rheumatol 1999;17:527-32.
116. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the 'sawtooth' strategy. J Rheumatol 1990;17(Suppl. 22):12-5.
117. Edmonds JP, Scott DL, Furst DE, Brooks P, Paulus HE. Antirheumatic drugs: a proposed new classification. Arthritis Rheum 1993;36:336-9.
118. Paulus HE, Bulpitt KJ. DC-ART classification: Review of relevant clinical studies. J Rheumatol 1994;21:8-11.
119. Gilkeson G, Polisson R, Sinclair H et al. Early detection of carpal erosions in patients with rheumatoid arthritis: A pilot study of magnetic resonance imaging. J Rheumatol 1988;15:1361-6.
120. Wakefield RJ, Gibbon WW, Emery P. The current status of ultrasonography in rheumatology. [Editorial]. Rheumatology 1998;38:195-8.
121. McGonagle D, Conaghan PG, O'Connor P et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 1999; 42:1706-11.
122. Klarlund M, Ostergaard M, Rostrup E, Skjodt H, Lorenzen I. Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis, and healthy controls. Scand J Rheumatol 2000;29:108-15.
123. Fleming A, Benn RT, Corbett M, Wood PHN. Early rheumatoid disease: II. Patterns of joint involvement. Ann Rheum Dis 1976;35:361-4.
124. Bukhari M, Harrison B, Lunt M, Scott DGI, Symmons DPM, Silman AJ. Time to first occurrence of erosions in inflammatory polyarthritis. Results from a prospective community-based study. Arthritis Rheum 2001;44:1248-53.